New data reveals that retatrutide, a dual-action medication, could represent a major advance in weight loss . This therapy combines the actions of a GLP-1 receptor and a GIP receptor , possibly offering a https://seolistlinks.com/story23164628/the-new-breakthrough-for-weight-regulation